Press Releases

MicrobioSeq Releases Nanopore-Based Microbial Epigenomics Solutions to Accelerate Your Research

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.

STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.

Amerigo Scientific Supports Microbiology Research with the Launch of HHD BROTH

Amerigo Scientific now introduces HHD Broth to the life science research community.

Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

Creative Diagnostics recently launches recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA).

Daman enters collaboration to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)

Daman has announced they have signed an agreement with Janssen Pharmaceutica NV (Janssen) to deliver a digital health tool to be used in a clinical study among people living with psoriatic arthritis.

ENPICOM launches versatile display data analysis solution to accelerate antibody selection while maximizing precision

ENPICOM has announced the upcoming expansion of the capabilities of the IGX Platform to unlock seamless analysis of antibody panning data.

Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development

Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research

Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

Indica Labs achieves CE-IVD certification for AI-based Prostate Cancer Detection and Gleason Grading Tool

Indica Labs has announced it has achieved a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies.

mdgroup Growth sees New VP, Product Delivery, Investing for the Future

mdgroup Growth sees New VP, Product Delivery, Investing for the Future Bracknell, UK: 19 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, has charged its new VP, Product Delivery, Mohamad (Mo) Merhi, with doubling the development team and recruiting the highest calibre of global talent in technological development and innovation.

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Synexa Life Sciences BV has announced that it has acquired Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development.

LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR ABEMACICLIB (VERZENIOS®▼) IN COMBINATION WITH ENDOCRINE THERAPY FOR ADJUVANT TREATMENT OF People with HR+, HER2- HIGH RISK EARLY BREAST CANCER

AI and Automation in Clinical Trials

“The destiny of Clinical Research is AI”! It’s not unusualplace location to pay attention this now a days however what does it mean? We have all heard of the way AI is being implemented in simple studies in figuring out molecules, in locating ailment styles in capability affected person populations and in Virtual Trials. In this newsletter I will in short comment on the diverse widely known and some lesser-acknowledged programs of AI and Automation withinside the scientific trials process.

Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress

BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.

Source the Best PseudoUridines at Industry-Renowned Exhibitions

BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.

Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards

Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.

How to Synthesize Wax Esters? Three Synthetic Routes

Wax esters are esters formed by long-chain fatty acids and fatty alcohols. Owing to their biodegradability and good lubricity, wax esters can be used as base materials for advanced lubricants and advanced emollient oils for aviation, machinery, and chemical industries as well as for daily cosmetics and other fields. Wax esters can be divided into saturated and unsaturated types.

CD Formulation: How to Select Pharmaceutical Excipients

Pharmaceutical excipients can be classified into natural, semi-synthetic and fully synthetic compounds according to their sources. And based on their use, excipients can be divided into diluents, binders, disintegrants, lubricants, glidants and anti-caking agents, wetting agents and solubilizers.